Comparative genomic hybridization in cartilaginous tumors

Anticancer Research

Volumn 24, Issue 3 A, 2004, Pages 1721-1725

  Ozaki, Toshifumi ^a,d   Wai, Daniel ^b   Schäfer, Karl Ludwig ^b   Lindner, Norbert ^a   Böcker, Werner ^b   Winkelmann, Winfried ^a   Dockhorn Dworniczak, Barbara ^c   Poremba, Christopher ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c Institute of Pathology   (Germany)

^d OKAYAMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Cartilaginous tumors; Chondrosarcomas; Genomic hybridization

Indexed keywords

ADULT; ARTICLE; CARTILAGE TUMOR; CHONDROMYXOID FIBROMA; CHONDROSARCOMA; CHROMOSOME 11; CHROMOSOME 13Q; CHROMOSOME 15; CHROMOSOME 16P; CHROMOSOME 17P; CHROMOSOME 18; CHROMOSOME 19; CHROMOSOME 2; CHROMOSOME 21; CHROMOSOME 21Q; CHROMOSOME 22Q; CHROMOSOME 5P; CHROMOSOME 7Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME LOSS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; ENCHONDROMA; FEMALE; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL;

ADULT; BONE NEOPLASMS; CHONDROMA; CHONDROSARCOMA; CHROMOSOME ABERRATIONS; FEMALE; FIBROMA; HUMANS; MALE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION;

EID: 3242736668     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Unni KK: Chondrosarcoma (primary, secondary, dedifferentiated, and clear cell). In: Dahlin's Bone Tumors. General Aspects and Data on 11,087 Cases. edited by Unni KK, Philadelphia, Lippincott-Raven, 1996, pp 71-108.
2. Schajowicz F: Tumor and Tumorlike Lesions of Bone. Pathology, Radiology, and Treatment. Berlin, Springer-Verlag, 1994.
3. Barnes R and Catto M: Chondrosarcoma of bone. J Bone Joint Surg Br 48: 729-764, 1966.
4. Huvos AG: Chondrosarcoma including spindle-cell (dedifferentiated) and myxoid chondrosarcoma; mesenchymal chondrosarcoma. In: Bone Tumor. Diagnosis, Treatment, and Prognosis. (vol 2), edited by AG H, Philadelphia, WB Saunders, 1991, pp 343-393.
5. Meachim G: Histological grading of chondrosarcoma (editorial). J Bone Joint Surg Br 61: 393-394, 1977.
6. Ozaki T, Hillmann A, Lindner N, Blasius S and Winkelmann W: Metastasis of chondrosarcoma. J Cancer Res Clin Oncol 122: 625-628, 1996.
7. Bjornsson J, McLeod RA, Unni KK, Ilstrup DM and Pritchard DJ: Primary chondrosarcoma of long bones and limb girdles. Cancer 83: 2105-2119, 1998
8. Larramendy ML, Mandahl N, Mertens F, Blomqvist C, Kivioja AH, Karaharju E, Valle J, Bohling T, Tarkkanen M, Rydholm A, Akerman M, Bauer HC, Anttila JP, Elomaa I and Knuutila S: Clinical significance of genetic imbalances revealed by comparative genomic hybridization in chondrosarcomas. Hum Pathol 30: 1247-1253, 1999.
9. Bovee JV, Cleton-Jansen AM, Rosenberg C, Taminiau AH, Cornelisse CJ and Hogendoorn PC: Molecular genetic characterization of both components of a dedifferentiated chondrosarcoma, with implications for its histogenesis. J Pathol 189: 454-462, 1999.
10. Evans HL, Ayala AG and Romsdahl MM: Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading. Cancer 40: 818-831, 1977.
11. Enneking WF, Spanier SS and Goodman MA: A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop 153: 106-120, 1980.
12. Paulussen M, Ahrens S, Braun-Munzinger G, Craft AW, Dockhorn-Dworniczak B, Dorffel W, Dunst J, Frohlich B, Gobel U, Haussler M, Klingebiel T, Koscielniak E, Mittler U, Rube C, Winkelmann W, Voute PA, Zoubek A and Jurgens H: EICESS 92 (European Intergroup Cooperative Ewing's Sarcoma Study) - preliminary results. Klin Padiatr 211: 276-283, 1999.
13. Kallioniemi OP, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW and Pinkel D: Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 10: 231-243, 1994.
14. Brinkschmidt C, Poremba C, Christiansen H, Simon R, Schafer KL, Terpe HJ, Lampert F, Boecker W and Dockhorn-Dworniczak B: Comparative genomic hybridization and telomerase activity analysis identify two biologically different groups of 4s neuroblastomas. Br J Cancer 77: 2223-2229, 1998.
15. Scheel C, Schaefer KL, Jauch A, Keller M, Wai D, Brinkschmidt C, van Valen F, Boecker W, Dockhorn-Dworniczak B and Poremba C: Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas. Oncogene 20: 3835-3844, 2001.
16. O'Donovan M, Russell JM, O'Leary JJ, Gillan JA, Lawler MP and Gaffney EF: Abl expression, tumour grade, and apoptosis in chondrosarcoma. Mol Pathol 52: 341-344, 1999.
17. Kohda T, Asai A, Kuroiwa Y, Kobayashi S, Aisaka K, Nagashima G, Yoshida MC, Kondo Y, Kagiyama N, Kirino T, Kaneko-Ishino T and Ishino F: Tumour suppressor activity of human imprinted gene PEG3 in a glioma cell line. Genes Cells 6: 237-247, 2001.
18. Smith JS, Tachibana I, Lee HK, Qian J, Pohl U, Mohrenweiser HW, Borell TJ, Hosek SM, Soderberg CL, von Deimling A, Perry A, Scheithauer BW, Louis DN and Jenkins RB: Mapping of the chromosome 19 q-arm glioma tumor suppressor gene using fluorescence in situ hybridization and novel microsatellite markers. Genes Chromosomes Cancer 29: 16-25, 2000.
19. Smith JS, Tachibana I, Pohl U, Lee HK, Thanarajasingam U, Portier BP, Ueki K, Ramaswamy S, Billings SJ, Mohrenweiser HW, Louis DN and Jenkins RB: A transcript map of the chromosome 19q-arm glioma tumor suppressor region. Genomics 64: 44-50, 2000.
20. Yamaguchi T, Toguchida J, Wadayama B, Kanoe H, Nakayama T, Ishizaki K, Ikenaga M, Kotoura Y and Sasaki MS: Loss of heterozygosity and tumor suppressor gene mutations in chondrosarcomas. Anticancer Res 16: 2009-2015, 1996.
21. Balsara BR, Sonoda G, du Manoir S, Siegfried JM, Gabrielson E and Testa JR: Comparative genomic hybridization analysis detects frequent, often high- level, overrepresentation of DNA sequences at 3q, 5p, 7p, and 8q in human non-small cell lung carcinomas. Cancer Res 57: 2116-2120, 1997.
22. Tarkkanen M, Elomaa I, Blomqvist C, Kivioja AH, Kellokumpu-Lehtinen P, Bohling T, Valle J and Knuutila S: DNA sequence copy number increase at 8q: a potential new prognostic marker in high-grade osteosarcoma. Int J Cancer 84: 114-121, 1999.
23. Simons A, Schepens M, Jeuken J, Sprenger S, van de Zande G, Bjerkehagen B, Forus A, Weibolt V, Molenaar I, van den Berg E, Myklebost O, Bridge J, van Kessel AG and Suijkerbuijk R: Frequent loss of 9p21 (p16 (INK4A)) and other genomic imbalances in human malignant fibrous histiocytoma. Cancer Genet Cytogenet 118: 89-98, 2000.
24. Zhang H, Kobayashi R, Galaktionov K and Beach D: p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase. Cell 82: 915-925, 1995.
25. Ouyang P: An in vitro model to study mesenchymal-epithelial transformation. Biochem Biophys Res Commun 246: 771-776, 1998.
26. Naka T, Iwamoto Y, Shinohara N, Ushijima M, Chuman H and Tsuneyoshi M: Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors. Mod Pathol 10: 832-838, 1997.
27. Sakai Y, Saijo M, Coelho K, Kishino T, Niikawa N and Taya Y: cDNA sequence and chromosomal localization of a novel human protein, RBQ-1 (RBBP6), that binds to the retinoblastoma gene product. Genomics 30: 98-101, 1995.